Amneal Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	201.25	110.55	91.54	25.98	247.79	341.38
Short-Term Investments	2.23	1.87	2.2	1.82	1.17	1.7
Cash & Short-Term Investments	203.48	112.42	93.74	27.8	248.96	343.07
Cash Growth	163.37%	19.93%	237.24%	-88.83%	-27.43%	125.23%
Accounts Receivable	885.2	775.73	613.73	741.79	662.58	639
Other Receivables	38.94	32.83	31.93	54.62	32.06	29.22
Receivables	924.14	808.56	645.66	796.41	694.64	668.21
Inventory	614.5	612.45	581.38	530.74	489.39	490.65
Prepaid Expenses	61.64	46.5	49.51	47.13	45.07	37.86
Restricted Cash	34.73	7.87	7.57	9.25	8.95	5.74
Other Current Assets	-	-	-	0.5	33.1	6
Total Current Assets	1,838	1,588	1,378	1,412	1,520	1,552
Property, Plant & Equipment	538.06	523.69	550.14	589.36	639	604.71
Long-Term Investments	5.17	35.92	37.09	85.59	-	-
Goodwill	595.95	597.44	598.63	598.85	593.02	522.81
Other Intangible Assets	587.94	732.38	890.42	1,096	1,167	1,305
Long-Term Deferred Charges	5.49	2.82	4.43	2.21	1.6	2.65
Other Long-Term Assets	28.8	21.39	14	15.43	19.01	19.7
Total Assets	3,600	3,501	3,473	3,799	3,940	4,006
Accounts Payable	266.7	259.84	145.53	166.84	132.87	154.14
Accrued Expenses	289.5	307.31	246.01	218.21	220.57	257.98
Short-Term Debt	-	100	179	60	-	-
Current Portion of Long-Term Debt	7.2	224.21	34.13	29.96	30.61	45.23
Current Portion of Leases	14.27	16.04	14.5	14.68	15.42	12.25
Current Income Taxes Payable	-	-	-	-	2.52	5.54
Other Current Liabilities	284.44	222.36	227.43	263.11	275.24	201.77
Total Current Liabilities	862.11	1,130	846.6	752.8	677.24	676.9
Long-Term Debt	2,567	2,162	2,427	2,632	2,730	2,826
Long-Term Leases	97.75	91.09	95.45	108.81	111.93	115.74
Other Long-Term Liabilities	115.69	163.33	41.77	97.12	37.05	31.05
Total Liabilities	3,642	3,546	3,411	3,590	3,556	3,649
Common Stock	3.14	3.1	3.07	3.04	3.01	3
Additional Paid-In Capital	563.36	560.21	539.24	691.63	658.35	628.41
Retained Earnings	-570.08	-607.06	-490.18	-406.18	-276.2	-286.82
Comprehensive Income & Other	-105.88	-65.51	-32.35	9.94	-24.83	-41.32
Total Common Equity	-109.46	-109.27	19.78	298.42	360.34	303.27
Minority Interest	67.28	64.73	41.52	-89.49	23.54	53.47
Shareholders' Equity	-42.18	-44.54	61.3	208.93	383.88	356.74
Total Liabilities & Equity	3,600	3,501	3,473	3,799	3,940	4,006
Total Debt	2,686	2,593	2,751	2,845	2,888	2,999
Net Cash (Debt)	-2,482	-2,481	-2,657	-2,817	-2,639	-2,656
Net Cash Per Share	-7.75	-8.03	-15.08	-18.66	-17.38	-17.83
Filing Date Shares Outstanding	314.36	309.97	307.01	151.5	149.42	147.7
Total Common Shares Outstanding	314.31	309.88	306.57	151.49	149.41	147.67
Working Capital	976.37	458.04	531.27	659.02	842.87	874.64
Book Value Per Share	-0.35	-0.35	0.06	1.97	2.41	2.05
Tangible Book Value	-1,293	-1,439	-1,469	-1,397	-1,400	-1,524
Tangible Book Value Per Share	-4.11	-4.64	-4.79	-9.22	-9.37	-10.32
Land	-	8.11	9.02	10.71	11.54	4.94
Buildings	-	224.66	227.84	225.63	230.99	210.12
Machinery	-	546.56	524.61	485.44	484.42	414.68
Construction In Progress	-	78.2	67.67	69.34	58.26	71.46
Leasehold Improvements	-	130.91	126.46	124.67	123.51	108.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.